• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

知情同意与教育对退伍军人健康管理局启动阿片类药物治疗后护理参与度的影响。

Impact of Informed Consent and Education on Care Engagement After Opioid Initiation in the Veterans Health Administration.

作者信息

Avoundjian Tigran, Troszak Lara, Cohen Jennifer, Foglia Mary Beth, Trafton Jodie, Midboe Amanda

机构信息

Center for Innovation to Implementation, Va Palo Alto Health Care System, Palo Alto, CA, USA.

School of Medicine, Stanford University, Stanford, CA, USA.

出版信息

J Pain Res. 2022 May 25;15:1553-1562. doi: 10.2147/JPR.S317183. eCollection 2022.

DOI:10.2147/JPR.S317183
PMID:35642185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9148610/
Abstract

OBJECTIVE

To ensure all patients receiving long-term opioid therapy (LTOT) understand the risks, benefits and treatment alternatives, the Veterans Health Administration (VHA) released a national policy in 2014 to standardize a signature informed consent (SIC) process. We evaluated the impact of this policy on medical follow-up after LTOT initiation, a guideline recommended practice.

METHODS

Using VHA administrative data, we identified patients initiating LTOT between May 2013 and May 2016. We used an interrupted time series design to compare the monthly rates of medical follow-up within 30 days and primary care visits within 3 months after LTOT initiation across three periods: 12 months before the policy (Year 1); 12 months after policy release (Year 2); and 12-24 months after policy release, when the SIC process was mandatory (Year 3).

RESULTS

Among the 409,895 patients who experienced 758,416 LTOT initiations, medical follow-up within 30 days and primary care engagement within 3 months increased by 4% between Year 1 and Year 3. Compared to Year 1, patients in Year 3 were 1.12 times more likely to have any medical follow-up (95% CI: 1.10, 1.13) and 1.13 times more likely to have a primary care visit (95% CI: 1.12, 1.15). Facilities with a greater proportion of patients receiving SIC had increased medical follow-up (RR: 1.04, 95% CI: 1.01, 1.07) and primary care engagement (RR: 1.06, 95% CI: 1.03, 1.10).

CONCLUSION

The VHA's SIC policy is associated with increased medical follow-up among patients initiating LTOT, which may result in improved patient safety and has implications for other healthcare settings.

摘要

目的

为确保所有接受长期阿片类药物治疗(LTOT)的患者了解风险、益处及治疗替代方案,退伍军人健康管理局(VHA)于2014年发布了一项国家政策,以规范签署知情同意书(SIC)流程。我们评估了该政策对LTOT开始后医学随访的影响,这是一项指南推荐的做法。

方法

利用VHA行政数据,我们确定了2013年5月至2016年5月期间开始接受LTOT的患者。我们采用中断时间序列设计,比较了三个时间段LTOT开始后30天内的每月医学随访率和3个月内的初级保健就诊率:政策发布前12个月(第1年);政策发布后12个月(第2年);以及政策发布后12 - 24个月,即SIC流程为强制性的时期(第3年)。

结果

在经历758,416次LTOT开始的409,895名患者中,第1年和第3年之间,30天内的医学随访和3个月内的初级保健参与率提高了4%。与第1年相比,第3年的患者进行任何医学随访的可能性高1.12倍(95%置信区间:1.10, 1.13),进行初级保健就诊的可能性高1.13倍(95%置信区间:1.12, 1.15)。接受SIC的患者比例较高的机构,其医学随访(相对风险:1.04,95%置信区间:1.01, 1.07)和初级保健参与率(相对风险:1.06,95%置信区间:1.03, 1.10)有所增加。

结论

VHA的SIC政策与开始接受LTOT的患者医学随访增加相关,这可能会提高患者安全性,并对其他医疗环境产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a2c/9148610/63bc0838185f/JPR-15-1553-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a2c/9148610/bccc4c0d7732/JPR-15-1553-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a2c/9148610/63bc0838185f/JPR-15-1553-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a2c/9148610/bccc4c0d7732/JPR-15-1553-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a2c/9148610/63bc0838185f/JPR-15-1553-g0002.jpg

相似文献

1
Impact of Informed Consent and Education on Care Engagement After Opioid Initiation in the Veterans Health Administration.知情同意与教育对退伍军人健康管理局启动阿片类药物治疗后护理参与度的影响。
J Pain Res. 2022 May 25;15:1553-1562. doi: 10.2147/JPR.S317183. eCollection 2022.
2
Signature Informed Consent for Long-Term Opioid Therapy in Patients With Cancer: Perspectives of Patients and Providers.癌症患者长期阿片类药物治疗的知情同意书:患者和提供者的观点。
J Pain Symptom Manage. 2020 Jan;59(1):49-57. doi: 10.1016/j.jpainsymman.2019.08.020. Epub 2019 Aug 30.
3
Association Between Facility-Level Utilization of Non-pharmacologic Chronic Pain Treatment and Subsequent Initiation of Long-Term Opioid Therapy.医疗机构中非药物慢性疼痛治疗的使用与随后长期阿片类药物治疗的启动之间的关联。
J Gen Intern Med. 2018 May;33(Suppl 1):38-45. doi: 10.1007/s11606-018-4324-y.
4
5
6
Impact of Mandated Case Review Policy on Opioid Discontinuation and Mortality Among High-Risk Long-Term Opioid Therapy Patients: The STORM Stepped-Wedge Cluster Randomized Controlled Trial.强制性病例审查政策对高风险长期阿片类药物治疗患者阿片类药物停药和死亡率的影响:STORM 渐进式楔形集群随机对照试验。
Subst Abus. 2023 Oct;44(4):292-300. doi: 10.1177/08897077231198299. Epub 2023 Oct 13.
7
The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality.遵循指南的长期阿片类药物治疗与全因死亡率之间的关联。
J Gen Intern Med. 2016 May;31(5):492-501. doi: 10.1007/s11606-015-3571-4.
8
The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality.物质使用障碍对符合指南的长期阿片类药物治疗与全因死亡率之间关联的影响。
J Addict Med. 2016 Nov/Dec;10(6):418-428. doi: 10.1097/ADM.0000000000000255.
9
Trajectories of Opioid Coverage After Long-Term Opioid Therapy Initiation Among a National Cohort of US Veterans.美国退伍军人全国队列中启动长期阿片类药物治疗后的阿片类药物覆盖轨迹
J Pain Res. 2021 Jun 14;14:1745-1762. doi: 10.2147/JPR.S308196. eCollection 2021.
10
COVID-19 outcomes among adult patients treated with long-term opioid therapy for chronic non-cancer pain in the USA: a retrospective cohort study.美国接受长期阿片类药物治疗慢性非癌性疼痛的成年患者的 COVID-19 结局:一项回顾性队列研究。
BMJ Open. 2021 Nov 26;11(11):e056436. doi: 10.1136/bmjopen-2021-056436.

本文引用的文献

1
Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.阿片类药物长期用于慢性非癌性疼痛的相关不良事件:Cochrane系统评价概述
Cochrane Database Syst Rev. 2017 Oct 30;10(10):CD012509. doi: 10.1002/14651858.CD012509.pub2.
2
Shared Medical Decision Making in Consideration of Opioid Therapy in a Patient With Restless Legs Syndrome.
Continuum (Minneap Minn). 2017 Aug;23(4, Sleep Neurology):1151-1155. doi: 10.1212/CON.0000000000000493.
3
A multicentre evaluation of an opioid patient-provider agreement.阿片类药物患者-提供者协议的多中心评估。
Postgrad Med J. 2017 Oct;93(1104):613-617. doi: 10.1136/postgradmedj-2016-134607. Epub 2017 May 10.
4
Addressing the Opioid Epidemic in the United States: Lessons From the Department of Veterans Affairs.应对美国的阿片类药物流行:来自退伍军人事务部的经验教训。
JAMA Intern Med. 2017 May 1;177(5):611-612. doi: 10.1001/jamainternmed.2017.0147.
5
Breaking the pain contract: A better controlled-substance agreement for patients on chronic opioid therapy.打破疼痛契约:为慢性阿片类药物治疗患者制定更好的受控物质协议。
Cleve Clin J Med. 2016 Nov;83(11):827-835. doi: 10.3949/ccjm.83a.15172.
6
Interrupted time series regression for the evaluation of public health interventions: a tutorial.中断时间序列回归在公共卫生干预措施评价中的应用:教程。
Int J Epidemiol. 2017 Feb 1;46(1):348-355. doi: 10.1093/ije/dyw098.
7
Sedation shared decision-making in ambulatory venous access device placement: Effects on patient choice, satisfaction and recovery time.门诊静脉通路装置置入术中的镇静共同决策:对患者选择、满意度及恢复时间的影响
Vasc Med. 2016 Aug;21(4):355-60. doi: 10.1177/1358863X16643602. Epub 2016 Apr 13.
8
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49. doi: 10.15585/mmwr.rr6501e1.
9
Twelve myths about shared decision making.关于共同决策的十二个误区。
Patient Educ Couns. 2014 Sep;96(3):281-6. doi: 10.1016/j.pec.2014.06.014. Epub 2014 Jul 3.
10
Chronic pain and opioid use in US soldiers after combat deployment.美国士兵战斗部署后的慢性疼痛与阿片类药物使用情况
JAMA Intern Med. 2014 Aug;174(8):1400-1. doi: 10.1001/jamainternmed.2014.2726.